The authors provide perspectives on how cyclosporine is currently being used clinically in the treatment of ocular disorders, without providing a definitive commentary on efficacy or specific recommendations for therapy 339 MAJOR REVIEW. Cardiovascular Risk and Antiangiogenic Therapy for Age-related Macular Degeneration.